CoChat

“Re-educating” tumor-associated macrophages by targeting NF-κB

Open access

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

The nuclear factor κB (NF-κB) signaling pathway is important in cancer-related inflammation and malignant progression. Here, we describe a new role for NF-κB in cancer in maintaining the immunosuppressive phenotype of tumor-associated macrophages (TAMs). We show that macrophages are polarized via interleukin (IL)-1R and MyD88 to an immunosuppressive “alternative” phenotype that requires IκB kinase β–mediated NF-κB activation. When NF-κB signaling is inhibited specifically in TAMs, they become cytotoxic to tumor cells and switch to a “classically” activated phenotype; IL-12high, major histocompatibility complex IIhigh, but IL-10low and arginase-1low. Targeting NF-κB signaling in TAMs also promotes regression of advanced tumors in vivo by induction of macrophage tumoricidal activity and activation of antitumor activity through IL-12–dependent NK cell recruitment. We provide a rationale for manipulating the phenotype of the abundant macrophage population already located within the tumor microenvironment; the potential to “re-educate” the tumor-promoting macrophage population may prove an effective and novel therapeutic approach for cancer that complements existing therapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20080108

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. IKKβ inhibition increases macrophage tumoricidal activity. (A) WT, MyD88−/−, TLR-2−/−, and TLR-4−/− or mock, IKKβDN or IKKβf/f, and IKKβΔ BMDMs were co-cultured with ID8-Luc in a modified Boyden chamber without direct cell–cell contact for 72 h. In addition, CD11b+-selected TAMs from the ascites of ID8 tumor–bearing mice were mock (TAMmock) or IKKβDN infected (TAMDN). Invasion of ID8-Luc cells was assessed by luciferase activity in the lower part of the chamber. Macrophages deleted in MyD88, IL-1R, or IKKβ significantly reduce ID8-Luc invasion (P < 0.01; t test with Welch's correction). Data are represented as mean ± SEM of n = 6. Representative data are shown from at least three independent experiments. (B) ID8 cells were co-cultured with IKKβ-targeted BMDMs or TAMs and respective control cells. Fluorescence caspase 3/7 activity was assessed after 0, 3, and 6 h. Co-culture with IKKβDN and IKKβΔ BMDMs or TAMs expressing IKKβDN (TAMDN) significantly increases caspase 3/7 activity in ID8 cells (P < 0.01; t test with Welch's correction). Data are represented as mean ± SD of n = 6. Representative data are shown from at least three independent experiments. (C) [111In]oxine release assay after a 24-h co-culture of 111In-labeled ID8 cells with mock, IKKβDN, TAMDN or IKKβf/f, and IKKβΔ macrophages. 111In-release in cell-free culture supernatants was measured after 24 h with a scintillation counter. IKKβ-targeted macrophages promote increased cytotoxicity. Data are represented as mean of n = 3. Representative data are shown from at least three independent experiments.
Figure 1. IKKβ inhibition increases macrophage tumoricidal activity. (A) WT, MyD88−/−, TLR-2−/−, and TLR-4−/− or mock, IKKβDN or IKKβf/f, and IKKβΔ BMDMs were co-cultured with ID8-Luc in a modified Boyden chamber without direct cell–cell contact for 72 h. In addition, CD11b+-selected TAMs from the ascites of ID8 tumor–bearing mice were mock (TAMmock) or IKKβDN infected (TAMDN). Invasion of ID8-Luc cells was assessed by luciferase activity in the lower part of the chamber. Macrophages deleted in MyD88, IL-1R, or IKKβ significantly reduce ID8-Luc invasion (P < 0.01; t test with Welch's correction). Data are represented as mean ± SEM of n = 6. Representative data are shown from at least three independent experiments. (B) ID8 cells were co-cultured with IKKβ-targeted BMDMs or TAMs and respective control cells. Fluorescence caspase 3/7 activity was assessed after 0, 3, and 6 h. Co-culture with IKKβDN and IKKβΔ BMDMs or TAMs expressing IKKβDN (TAMDN) significantly increases caspase 3/7 activity in ID8 cells (P < 0.01; t test with Welch's correction). Data are represented as mean ± SD of n = 6. Representative data are shown from at least three independent experiments. (C) [111In]oxine release assay after a 24-h co-culture of 111In-labeled ID8 cells with mock, IKKβDN, TAMDN or IKKβf/f, and IKKβΔ macrophages. 111In-release in cell-free culture supernatants was measured after 24 h with a scintillation counter. IKKβ-targeted macrophages promote increased cytotoxicity. Data are represented as mean of n = 3. Representative data are shown from at least three independent experiments.CC BY-NC-SA · PubMed Central
Figure 2. IKKβ maintains the alternative phenotype of tumor-polarized macrophages. WT, mock, IKKβDN or IKKβf/f, and IKKβΔ BMDMs were co-cultured with ID8 cells for 24 h. Supernatant was collected after 24 h and analyzed for IL-10, IL-12p70, TNF-α, and NO production by ELISA. (A) Co-cultured WT macrophages express an immunosuppressive IL-10high IL-12p70low TNF-αhigh profile. However, supernatant from co-cultured IKKβ-deleted macrophages show a significant decrease in IL-10 and TNF-α (P < 0.01; t test with Welch's correction) but increase in IL-12p70 (P < 0.01; t test with Welch's correction). Data are represented as mean ± SD of n = 3. Representative data are shown from at least three independent experiments. (B) In parallel, total RNA was isolated for real-time PCR analysis of IL-12p40 and arginase-1 in co-cultured macrophages. Targeting IKKβ in macrophages switches their phenotype to an IL-12high arginase-1low NOS2high profile, consistent with an M1 phenotype. In_addition, IKKβ-targeted macrophages secrete significantly higher levels of NO, measured as nitrite by Griess assay (P < 0.01; Mann-Whitney test). Data are represented as mean ± SD of n = 3. Representative data are shown from at least four independent experiments. (C) Macrophages were co-cultured with ID8 cells, and protein extracts were prepared at the indicated time points for biochemical analysis. Expression of NF-κB p65, serine 536 phosphorylation of p65, IKKβ, Stat1, tyrosine 701 phosphorylation of Stat1 (Tyr701), and NOS2 was measured by immunoblot analysis of cell lysates using β-actin as a loading control. Representative data are shown from at least three independent experiments. (D) [111In]oxine release assay after co-culture of ID8 ovarian cancer cells with IKKβDN or IKKβΔ BMDMs. IKKβ-targeted macrophages promote increased cytotoxicity that was reversed by the addition of the selective NOS2 inhibitor 1400W. Data are represented as mean of n = 3. Representative data are shown from at least three independent experiments.
Figure 2. IKKβ maintains the alternative phenotype of tumor-polarized macrophages. WT, mock, IKKβDN or IKKβf/f, and IKKβΔ BMDMs were co-cultured with ID8 cells for 24 h. Supernatant was collected after 24 h and analyzed for IL-10, IL-12p70, TNF-α, and NO production by ELISA. (A) Co-cultured WT macrophages express an immunosuppressive IL-10high IL-12p70low TNF-αhigh profile. However, supernatant from co-cultured IKKβ-deleted macrophages show a significant decrease in IL-10 and TNF-α (P < 0.01; t test with Welch's correction) but increase in IL-12p70 (P < 0.01; t test with Welch's correction). Data are represented as mean ± SD of n = 3. Representative data are shown from at least three independent experiments. (B) In parallel, total RNA was isolated for real-time PCR analysis of IL-12p40 and arginase-1 in co-cultured macrophages. Targeting IKKβ in macrophages switches their phenotype to an IL-12high arginase-1low NOS2high profile, consistent with an M1 phenotype. In_addition, IKKβ-targeted macrophages secrete significantly higher levels of NO, measured as nitrite by Griess assay (P < 0.01; Mann-Whitney test). Data are represented as mean ± SD of n = 3. Representative data are shown from at least four independent experiments. (C) Macrophages were co-cultured with ID8 cells, and protein extracts were prepared at the indicated time points for biochemical analysis. Expression of NF-κB p65, serine 536 phosphorylation of p65, IKKβ, Stat1, tyrosine 701 phosphorylation of Stat1 (Tyr701), and NOS2 was measured by immunoblot analysis of cell lysates using β-actin as a loading control. Representative data are shown from at least three independent experiments. (D) [111In]oxine release assay after co-culture of ID8 ovarian cancer cells with IKKβDN or IKKβΔ BMDMs. IKKβ-targeted macrophages promote increased cytotoxicity that was reversed by the addition of the selective NOS2 inhibitor 1400W. Data are represented as mean of n = 3. Representative data are shown from at least three independent experiments.CC BY-NC-SA · PubMed Central
Figure 3. Adoptive transfer of IKKβ-targeted BMDMs inhibits tumor growth in vivo. (A) Representative bioluminescence imaging in vivo 14 d after adoptive transfer of BMDMs (n = 6; three independent experiments). ID8-Luc were injected i.p. into syngeneic mice and tumors were allowed to develop. After 35 d, WT, mock, and IKKβDN BMDMs were adoptively transferred and peritoneal cells were collected after an additional 7 and 14 d. Bioluminescence is presented as a pseudocolor scale: red, the highest photon flux; blue, the lowest photon flux. (B) Quantification of bioluminescence from primary tumors (n = 6 each) obtained on days 0, 7, and 14. Adoptively transferred IKKβDN BMDMs significantly reduced ID8 growth on day 14 (P < 0.05; t test with Welch's correction). (C) NO secretion into the peritoneal cavity. IKKβDN BMDMs increased NO release 4 h after adoptive transfer (P < 0.05; t test with Welch's correction). Data are represented as mean ± SD of n = 6. Representative data are shown from at least two independent experiments. (D) Cytokine profile in tumor ascites after 14 d. Ascites from mice treated with IKKβ-targeted BMDMs contained significantly lower amounts of IL-10 and TNF-α but higher amounts of IL-12 (P < 0.01; Mann-Whitney test). Total RNA was isolated from CD11b+-selected ascitic macrophages for real-time PCR analysis of IL-12p40 and arginase-1 expression. Data are represented as fold induction of mRNA expression compared with WT macrophages (n = 6). (E) MHC class II expression in the ascitic CD11b+ myeloid cell population measured by FACS (percentage of positive cells indicated). Representative histograms are shown from n = 6.
Figure 3. Adoptive transfer of IKKβ-targeted BMDMs inhibits tumor growth in vivo. (A) Representative bioluminescence imaging in vivo 14 d after adoptive transfer of BMDMs (n = 6; three independent experiments). ID8-Luc were injected i.p. into syngeneic mice and tumors were allowed to develop. After 35 d, WT, mock, and IKKβDN BMDMs were adoptively transferred and peritoneal cells were collected after an additional 7 and 14 d. Bioluminescence is presented as a pseudocolor scale: red, the highest photon flux; blue, the lowest photon flux. (B) Quantification of bioluminescence from primary tumors (n = 6 each) obtained on days 0, 7, and 14. Adoptively transferred IKKβDN BMDMs significantly reduced ID8 growth on day 14 (P < 0.05; t test with Welch's correction). (C) NO secretion into the peritoneal cavity. IKKβDN BMDMs increased NO release 4 h after adoptive transfer (P < 0.05; t test with Welch's correction). Data are represented as mean ± SD of n = 6. Representative data are shown from at least two independent experiments. (D) Cytokine profile in tumor ascites after 14 d. Ascites from mice treated with IKKβ-targeted BMDMs contained significantly lower amounts of IL-10 and TNF-α but higher amounts of IL-12 (P < 0.01; Mann-Whitney test). Total RNA was isolated from CD11b+-selected ascitic macrophages for real-time PCR analysis of IL-12p40 and arginase-1 expression. Data are represented as fold induction of mRNA expression compared with WT macrophages (n = 6). (E) MHC class II expression in the ascitic CD11b+ myeloid cell population measured by FACS (percentage of positive cells indicated). Representative histograms are shown from n = 6.CC BY-NC-SA · PubMed Central
Figure 4. Adoptive transfer of IKKβ-targeted TAMs inhibits tumor growth in vivo. (A) Representative bioluminescence imaging in vivo 14 d after adoptive transfer of TAMs isolated from established ID8 tumors (n = 6; three independent experiments). ID8-Luc were injected i.p. into syngeneic mice and tumors were allowed to develop. After 35 d, mock- and IKKβDN-infected TAMs (TAMmock, TAMDN, respectively) were adoptively transferred and peritoneal cells were collected after an additional 7 and 14 d. Bioluminescence is presented as a pseudocolor scale: red, the highest photon flux; blue, the lowest photon flux. (B) Quantification of bioluminescence from primary tumors (n = 6 each) obtained on days 0, 7, and 14. Adoptive transfer of TAMDN significantly reduced ID8 growth on day 14 (P < 0.05; t test with Welch's correction). (C) NO secretion into the peritoneal cavity. Transfer of TAMDN significantly increased NO production 4 h after adoptive transfer (P < 0.05; t test with Welch's correction). Data are represented as mean ± SD of n = 6. Representative data are shown from at least two independent experiments. (D) Cytokine profile in tumor ascites after 14 d. Ascitic fluid after transfer of TAMDN contained significantly lower amounts of IL-10 and TNF-α but higher amounts of IL-12 (P < 0.01; Mann-Whitney test). Total RNA was isolated from CD11b+-selected TAMs for real-time PCR analysis of IL-12p40 and arginase-1 expression. Data are represented as fold induction of mRNA expression compared with TAMmock-treated mice (n = 6). (E) MHC class II expression in the ascitic CD11b+ TAMs measured by FACS (percentage of positive cells indicated). Representative histograms are shown from n = 6.
Figure 4. Adoptive transfer of IKKβ-targeted TAMs inhibits tumor growth in vivo. (A) Representative bioluminescence imaging in vivo 14 d after adoptive transfer of TAMs isolated from established ID8 tumors (n = 6; three independent experiments). ID8-Luc were injected i.p. into syngeneic mice and tumors were allowed to develop. After 35 d, mock- and IKKβDN-infected TAMs (TAMmock, TAMDN, respectively) were adoptively transferred and peritoneal cells were collected after an additional 7 and 14 d. Bioluminescence is presented as a pseudocolor scale: red, the highest photon flux; blue, the lowest photon flux. (B) Quantification of bioluminescence from primary tumors (n = 6 each) obtained on days 0, 7, and 14. Adoptive transfer of TAMDN significantly reduced ID8 growth on day 14 (P < 0.05; t test with Welch's correction). (C) NO secretion into the peritoneal cavity. Transfer of TAMDN significantly increased NO production 4 h after adoptive transfer (P < 0.05; t test with Welch's correction). Data are represented as mean ± SD of n = 6. Representative data are shown from at least two independent experiments. (D) Cytokine profile in tumor ascites after 14 d. Ascitic fluid after transfer of TAMDN contained significantly lower amounts of IL-10 and TNF-α but higher amounts of IL-12 (P < 0.01; Mann-Whitney test). Total RNA was isolated from CD11b+-selected TAMs for real-time PCR analysis of IL-12p40 and arginase-1 expression. Data are represented as fold induction of mRNA expression compared with TAMmock-treated mice (n = 6). (E) MHC class II expression in the ascitic CD11b+ TAMs measured by FACS (percentage of positive cells indicated). Representative histograms are shown from n = 6.CC BY-NC-SA · PubMed Central
Figure 5. Increased IL-12–dependent NK cell recruitment. (A) Neutralizing IL-12p40 but not IL-23p19 rescued the antitumor effect of adoptively transferred IKKβDN BMDMs (P < 0.01; Mann-Whitney test). Data are represented as mean ± SEM of n = 6. Representative data are shown from two independent experiments. (B) Representative bioluminescence image of the IL-12p40–neutralizing experiment (n = 6). (C) Adoptive transfer of IKKβDN BMDMs increases NK cell recruitment in ID8 tumors (P < 0.01; Mann-Whitney test). Data are represented as mean ± SD of n = 6. Representative data are shown from two independent experiments. (D) Ex vivo NK cell cytotoxicity assay. Splenic DX5+-enriched NK cells were stimulated with ascites from tumor-bearing mice, which had either no treatment or were treated with adoptive transfer of mock or IKKβDN BMDMs. Ascites from mice treated by adoptive transfer of IKKβDN BMDMs led to a significant increase in NK cell–mediated tumor cell cytotoxicity (P < 0.01; t test with Welch's correction). The addition of a neutralizing antibody against IL-12p40 but not IL-23p19 or the respective control antibody rescued the increased tumoricidal effect. Data are represented as mean of n = 3. Representative data are shown from three independent experiments.
Figure 5. Increased IL-12–dependent NK cell recruitment. (A) Neutralizing IL-12p40 but not IL-23p19 rescued the antitumor effect of adoptively transferred IKKβDN BMDMs (P < 0.01; Mann-Whitney test). Data are represented as mean ± SEM of n = 6. Representative data are shown from two independent experiments. (B) Representative bioluminescence image of the IL-12p40–neutralizing experiment (n = 6). (C) Adoptive transfer of IKKβDN BMDMs increases NK cell recruitment in ID8 tumors (P < 0.01; Mann-Whitney test). Data are represented as mean ± SD of n = 6. Representative data are shown from two independent experiments. (D) Ex vivo NK cell cytotoxicity assay. Splenic DX5+-enriched NK cells were stimulated with ascites from tumor-bearing mice, which had either no treatment or were treated with adoptive transfer of mock or IKKβDN BMDMs. Ascites from mice treated by adoptive transfer of IKKβDN BMDMs led to a significant increase in NK cell–mediated tumor cell cytotoxicity (P < 0.01; t test with Welch's correction). The addition of a neutralizing antibody against IL-12p40 but not IL-23p19 or the respective control antibody rescued the increased tumoricidal effect. Data are represented as mean of n = 3. Representative data are shown from three independent experiments.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

Items 401–500 of 802

Metadata

Authors
Hagemann, T., Lawrence, T., McNeish, I., Charles, K. A., Kulbe, H., Thompson, R. G., Robinson, S. C., & Balkwill, F. R.
Affiliations
  • Queen Mary University of London (GB)
  • 1Centre for Cancer and Inflammation
Venue
The Journal of Experimental Medicine
Published
2008-05-19
Volume
205
Issue
6
Pages
1261-1268
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2105724560
Cited by
792
References
25
Citations by year
2026: 12 · 2025: 22 · 2024: 32 · 2023: 28 · 2022: 42 · 2021: 41 · 2020: 45 · 2019: 31 · 2018: 50 · 2017: 49 · 2016: 49 · 2015: 46 · 2014: 73 · 2013: 64 · 2012: 41
FWCI
23.04
Type
journal article
Language
en
Open access
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
  • Spiral (Imperial College London) (submittedVersion)
Funders
  • Wellcome Trust
  • Cancer Research UK
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
tumor-associated macrophages, NF-κB signaling, macrophage polarization, alternative macrophage activation, IκB kinase β, MyD88, interleukin-1 receptor, IL-12, NK cell recruitment, tumor immunosuppression, tumor microenvironment, antitumor immunity, tumor regression
MeSH terms
Animals, Cell Differentiation, Humans, Immunosuppression Therapy, Macrophages, Neoplasms, Phenotype, Signal Transduction, NF-kappa B, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.